CHIANG MAI ALIST CLINIC
| タイ | トルコ | オーストリア | |
| 陽子線治療 | から $90,000 / 3,060,000฿ | から $70,000 / 2,380,000฿ | から $80,000 / 2,720,000฿ |
| 陽子線治療 | から $45,000 / 1,530,000฿ | から $30,000 / 1,020,000฿ | から $80,000 / 2,720,000฿ |
| 乳がんに対する陽子線治療 | から $50,000 / 1,700,000฿ | から $30,000 / 1,020,000฿ | から $55,000 / 1,870,000฿ |
Bookimedは陽子線治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで陽子線治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。陽子線治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。陽子線治療の旅路でお一人になることはありません。
Patients can receive proton-beam therapy in Bangkok at the HRH Princess Maha Chakri Sirindhorn Proton Center (HPSP) and the Oxyion Proton Therapy Center. These facilities specialize in treating complex pediatric, spinal, and prostate cancers using high-precision radiation that spares healthy surrounding tissues.
Bookimed Expert Insight: While Thailand offers world-class medical tourism, proton therapy is centralized in Bangkok. Patients should choose clinics like those partnered with Bumrungrad for streamlined logistics. These centers manage the 4-8 week stay required for full treatment cycles efficiently.
Patient Consensus: International patients highlight significant savings and efficient 20-minute treatment sessions. They recommend securing a medical visa extension early for the multi-week recovery period.
Proton-beam therapy in Thailand demonstrates high success, with five-year survival rates for pediatric patients reaching 80% to 90%. Specialized centers report local control rates between 90.8% for early-stage lung cancer and 95% for low-risk prostate cases, matching top-tier international clinical benchmarks.
Bookimed Expert Insight: Thailand's high success rates stem from the concentration of advanced technology in select academic centers. The Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center was the first in Southeast Asia. This early adoption means Thai radiation oncologists have managed complex cases longer than most regional peers.
Patient Consensus: Many patients emphasize that 90% biochemical control for prostate cancer aligns with global standards. They highlight the importance of following strict imaging schedules to maintain these high success figures.
Proton-beam therapy is best suited for localized solid tumors situated near critical organs or sensitive structures. This precision treatment is the gold standard for pediatric cancers, skull-base tumors, and ocular melanomas where sparing surrounding healthy tissue is vital for preserving life-sustaining functions.
Bookimed Expert Insight: While proton therapy is highly advanced, it is not a universal solution for all stages. Data shows it is most effective for stationary, localized targets rather than widespread metastases. Patients seeking treatment in Thailand can access this technology at approximately 1/3 the cost of US facilities while receiving care from English-speaking specialists at top-tier centers.
Patient Consensus: Many families choose this for pediatric cases to avoid long-term growth issues. Patients with prostate or eye cancers frequently report high satisfaction due to the significant reduction in life-altering side effects.
Thai government insurance schemes like the Universal Coverage Scheme (UCS) and Civil Servant Medical Benefit Scheme (CSMBS) cover proton-beam therapy under strict clinical necessity. Eligibility primarily includes pediatric patients under 15 and adults where conventional radiation poses high risks to healthy tissue.
Bookimed Expert Insight: While government schemes offer a vital safety net, the strict criteria mean many patients seek private options. Private facilities like Wattanosoth Cancer Hospital are expanding capacity, but expect out-of-pocket costs to reach $90,000 or higher. Comparing these costs to Singapore or South Korea can reveal more immediate treatment availability.
Patient Consensus: Many patients find navigating the strict NHSO requirements challenging and often feel standard radiation is the only accessible option. Those pursuing proton therapy frequently prepare for significant out-of-pocket expenses or explore employer-sponsored plans for better access.
Thailand currently hosts one operational proton therapy facility, the Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center (HPSP) in Bangkok. It utilizes the Varian ProBeam Compact system, featuring pencil-beam scanning technology and a 360-degree rotating gantry to target complex tumors in both children and adults.
Bookimed Expert Insight: While HPSP is the primary public provider, high demand often leads to waitlists. Some Thai hospitals like Samitivej Sukhumvit maintain international referral partnerships. These programs provide seamless access to cyclotron-based systems in nearby regional hubs. This reflects a growing network beyond a single physical location.
Patient Consensus: Patients report that treatment sessions are efficient, often lasting only 15-20 minutes. Many emphasize the importance of English-speaking physicists for clear communication during the planning phase.
Proton-beam therapy offers superior precision by stopping radiation exactly at the tumour site. This eliminates the exit dose found in traditional radiation, significantly reducing damage to healthy organs. Studies show patients experience fewer severe side effects and lower rates of unplanned hospitalisation during treatment.
Bookimed Expert Insight: While proton therapy costs more, its value lies in sparing sensitive structures. In Thailand, subtype-specific pricing like A$62,100 to A$89,700 for prostate cancer reflects this targeted approach. Patients should request a comparative plan to see if protons provide a measurable advantage over modern photon radiation.
Patient Consensus: Patients value how this treatment spares healthy tissue near the brain, heart, and spine. Experience in Thailand shows it effectively reduces chronic fatigue and skin irritation for younger patients.
Eligibility for proton-beam therapy in Thailand depends on tumour location, patient vulnerability, and previous radiation history. Specialists prioritise paediatric oncology patients and adults with solid tumours situated near critical organs like the heart, brain, or spinal cord where ordinary X-rays may cause irreversible damage.
Bookimed Expert Insight: Thai oncology centres use proton-beam therapy strategically for tumours requiring zero exit dose. This is vital for ocular melanomas and spinal tumours where sparing nearby nerves is paramount. Patients should provide complete past radiation plans to ensure specialists can safely map the new treatment area.
Patient Consensus: Eligibility is strictly diagnosis-driven in Thailand. Patients find that providing detailed pathology and imaging upfront accelerates the specialist review. The precision in sparing healthy tissue makes the treatment a preferred choice for complex anatomy.
Proton-beam therapy in Thailand involves a detailed six to twelve-week process beginning with custom immobilisation and precision 3D mapping. Daily sessions typically last 30 to 60 minutes over five consecutive weekdays for three to eight weeks. This outpatient procedure ensures targeted cancer treatment with minimal damage to healthy tissue.
Bookimed Expert Insight: Analysis of protocol data indicates that positioning is the most critical time factor. While radiation delivery takes only five minutes, setup and daily X-ray verification require 30 minutes. Patients should choose accommodation near the clinic to manage the physical fatigue that builds throughout the daily course.
Patient Consensus: Daily sessions are quick but the overall multi-week schedule requires planning for unexpected delays. Patients in Thailand suggest staying close to the clinic and confirming follow-up scanning arrangements before returning home.
Proton-beam therapy is available in Bangkok at the Her Royal Highness Princess Maha Chakri Sirindhorn Proton Centre. Located at King Chulalongkorn Memorial Hospital, it was South East Asia’s first dedicated facility. Patients also access advanced radiation referrals through international oncology departments at Samitivej Srinakarin Hospital.
Bookimed Expert Insight: Thailand’s proton therapy landscape is shifting toward the private sector for international patients. While the public HPSP centre remains the primary provider, private hospitals like Samitivej Srinakarin manage the complex logistics and scheduling. This coordination is vital because proton therapy requires multiple consecutive sessions over several weeks.
Patient Consensus: Patients find that Samitivej Srinakarin Hospital handles the technical coordination and travel planning effectively. Most recommend confirming the specific proton system matches your diagnosis before arriving in Thailand.